Next |
home / stock / kalv / kalv message board
Subject | By | Source | When |
---|---|---|---|
znewcar1: $KALV hod6.24 | znewcar1 | investorshangout | 12/28/2022 7:21:21 PM |
I would not even buy the shares at $20. | Femto99 | investorshub | 02/11/2021 5:16:09 PM |
All in puts! | Femto99 | investorshub | 02/11/2021 4:02:31 PM |
znewcar1: KALV 114% v34,8M c33.50 f17,9M preMH51.3 HOD44.7 S28.9 | znewcar1 | investorshangout | 02/09/2021 9:17:38 PM |
Boom! Killed it with puts today! | Stock_Barber | investorshub | 02/09/2021 9:01:35 PM |
* * $KALV Video Chart 02-09-2021 * * | ClayTrader | investorshub | 02/09/2021 8:58:07 PM |
This company is a disaster... | Stock_Barber | investorshub | 02/09/2021 2:24:13 PM |
The company is delinquent. | make it happen | investorshub | 02/09/2021 2:19:12 PM |
? lol | make it happen | investorshub | 02/09/2021 2:18:59 PM |
They are hemorrhaging money. Have pretty much zero | make it happen | investorshub | 02/09/2021 1:04:05 PM |
$KALV Kalvista Pharma Trend Break | TFMG | investorshub | 06/24/2020 2:23:05 AM |
News: $KALV KalVista Pharmaceuticals Appoints Daniel B. Soland | whytestocks | investorshub | 04/22/2019 6:50:38 PM |
News: $KALV KalVista Pharmaceuticals to Present at Needham | whytestocks | investorshub | 04/03/2019 5:24:23 PM |
$KALV buy 28.87 | stocktrademan | investorshub | 04/02/2019 4:58:09 PM |
News: $KALV KalVista Pharmaceuticals Reports Fiscal Third Quarter Results | whytestocks | investorshub | 03/14/2019 12:20:40 PM |
Where is everyone? | countryrapper2000 | investorshub | 01/07/2018 9:44:49 AM |
$17.85 !! | TheFinalCD | investorshub | 10/10/2017 12:52:38 PM |
Sniffer rocket ship today!! Wheeee. $KALV | Lone Wolf | investorshub | 10/10/2017 12:52:02 PM |
$15.50 now ~ keep rollin | TheFinalCD | investorshub | 10/10/2017 12:48:13 PM |
http://m.nasdaq.com/article/sv-life-sciences-advisers-llc-buys-kalvista-pharmace | kondziu | investorshub | 02/10/2017 10:38:41 AM |
News, Short Squeeze, Breakout and More Instantly...
KalVista Pharmaceuticals Inc. Company Name:
KALV Stock Symbol:
NASDAQ Market:
KalVista Pharmaceuticals Inc. Website:
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced that William C. Fairey has been appointed to the Company’s Board of Directors, ef...
2024-04-12 19:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced its management will participate in a fireside chat at the 23 rd Annual Needham Virtu...